¼¼°èÀÇ Ç÷¼ÒÆÇ ½ÃÀå º¸°í¼­(2025³â)
Blood Platelets Global Market Report 2025
»óǰÄÚµå : 1750929
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,147,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,885,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,623,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç÷¼ÒÆÇ ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀÌ Àü¸ÁµÉ ¿¹Á¤ÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ¿Ü»ó »ç·ÊÀÇ Áõ°¡, Ç÷¾× ÀºÇà ¼öÀÇ Áõ°¡, µ¿Á¾ ¼öÇ÷ ¿ä¹ý¿¡ ´ëÇÑ ¼±È£ Áõ°¡, Àα¸ °í·ÉÈ­, »óó Ä¡À¯¿¡ ÀÖ¾î Ç÷¼ÒÆÇÀÇ Çʿ伺 Áõ°¡¿¡ ±âÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ±â°£¿¡ ¿¹»óµÇ´Â ÁÖ¿ä µ¿Çâ¿¡´Â ÀÚµ¿ Ç÷¼ÒÆÇ ¾ÆÆä·¹½Ã½º ½Ã½ºÅÛÀÇ °³¹ß, Ç÷¼ÒÆÇ º¸Á¸ ±â¼úÀÇ ¹ßÀü, Ç÷¼ÒÆÇÀ» dzºÎÇÏ°Ô Æ÷ÇÔÇÏ´Â Ç÷Àå(PRP) ¿ä¹ý, ¹éÇ÷±¸ ȯ¿ø Ç÷¼ÒÆÇÀ¸·ÎÀÇ Àüȯ, Àΰø Ç÷¼ÒÆÇ ´ëü¹°ÀÇ ÃâÇö, Ç÷¼ÒÆÇ Àå¾ÖÀÇ À¯ÀüÀÚ ÆíÁý, ÀÚµ¿ ±âÁõÀÚ ½ºÅ©¸®´× µîÀÌ ÀÖ½À´Ï´Ù.

Ç÷¾× ÁúȯÀÇ À¯º´·ü Áõ°¡´Â Ç÷¼ÒÆÇ ½ÃÀåÀÇ È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÏ´Â °ÍÀº ÁÖ·Î °í·É Àα¸¿¡ ±âÀÎÇÕ´Ï´Ù. ³ªÀÌ¿¡ µû¸¥ °ñ¼ö ±â´ÉÀÇ ÀÚ¿¬ÀûÀÎ ÀúÇÏ¿¡ ÀÇÇØ °í·ÉÀÚ´Â ºóÇ÷, Ç÷¼ÒÆÇ °¨¼ÒÁõ, ÀÀ°í Àå¾Ö µîÀÇ »óÅ¿¡ ºüÁö±â ½¬¿öÁö±â ¶§¹®ÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 4¿ù, È£ÁÖ¿¡ º»ºÎ¸¦ µÎ´Â ºñ¿µ¸® ´Üü ÆÛ½º Ç÷¾× ¿¬±¸¼Ò´Â Ç÷¾×ÀÀ°í ÀÎÀÚÀÇ ºÎÁ·À¸·Î Ç÷¾×ÀÌ Àß ±»¾îÁöÁö ¾Ê´Â µå¹® À¯Àü¼º ÁúȯÀÎ Ç÷¿ìº´À¸·Î Áø´Ü¹ÞÀº »ç¶÷ÀÇ ¼ö°¡ 2021³â 23¸¸ 3,577¸í¿¡¼­ 2022³â¿¡´Â 25¸¸ 7,146¸í¿¡ ´ÞÇß´Ù°í º¸°íÇß½À´Ï´Ù.

Ç÷¾× Ç÷¼ÒÆÇ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷Àº º¸Á¸ ±â°£À» ¿¬ÀåÇÏ°í °¡¿ë¼ºÀ» Çâ»ó½ÃŰ°í ¼öÇ÷ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÏ´Â Ç÷¾× ¼¾Å͸¦ Áö¿øÇϱâ À§ÇØ Ç÷¼ÒÆÇ Ç®¸µ°ú °°Àº Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. Ç÷¼ÒÆÇ Ç®¸µÀº ¿©·¯ ÀüÇ÷ ÇåÇ÷¿¡¼­ ¾òÀº Ç÷¼ÒÆÇÀ» °áÇÕÇÏ¿© ¼öÇ÷¿ë ´ÜÀÏ Ç÷¼ÒÆÇ ´ÜÀ§¸¦ ¸¸µé°í Ç÷¾× °ø±Þ °ü¸®¿¡¼­ °¡¿ë¼º, È¿À²¼º ¹× ÀÚ¿ø »ç¿ëÀ» °³¼±ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 2¿ù, ¹Ì±¹ ÀÇ·á±â¼ú±â¾÷ÀÎ Å׸£¸ð ºí·¯µå ¾Ø ¼¿ Å×Å©³î·ÎÁö½º´Â ¹Ì±¹ ½ÄǰÀǾ౹(FDA)ÀÇ Àΰ¡¸¦ ¹Þ¾Æ IMUGARD WB Ç÷¼ÒÆÇ Ç®¸µ ¼¼Æ®¸¦ Ãâ½ÃÇß½À´Ï´Ù. ÀÌ ±â¼ú Çõ½ÅÀº ÀüÇ÷ À¯·¡ Ç÷¼ÒÆÇÀÇ º¸Á¸ ±â°£À» 5ÀÏ¿¡¼­ 7ÀÏ·Î ¿¬ÀåÇÏ¿© ¼öÇ÷¿ë Ç÷¼ÒÆÇÀÇ °¡¿ë¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ¶ÇÇÑ ¼ö¿ä Áõ°¡¿Í ±âÁõÀÚ ºÎÁ·¿¡ ´ëÀÀÇϱâ À§ÇÑ ´ëü Ç÷¼ÒÆÇ °ø±ÞÀ» Á¦°øÇÏ¿© Ç÷¾× ¼¾ÅͰ¡ Àç°í °ü¸®¸¦ °­È­ÇÏ°í ³¶ºñ¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, Äڷγª ÅÂ¿Í È¸º¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

SHW
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Blood platelets, also known as thrombocytes, are small, disc-shaped cell fragments found in the blood that play a crucial role in clot formation and wound healing. They prevent excessive bleeding by adhering to damaged blood vessel walls, aggregating with other platelets, and releasing clotting factors to stabilize the clot and prevent significant blood loss. Produced in the bone marrow, platelets are vital for hemostasis and blood vessel repair.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The main types of platelets in the blood platelet market are whole blood-derived platelets and apheresis-derived platelets. Whole blood-derived platelets are obtained by separating platelets from a standard whole blood donation, often pooled from multiple donors for transfusion. These platelets are used for treating platelet function disorders, hemophilia, thrombocytopenia, and perioperative indications. The primary end-users of these platelets include hospitals, ambulatory surgical centers, blood banks, research laboratories, specialty clinics, cancer treatment centers, trauma centers, and others.

The blood platelets market research report is one of a series of new reports from The Business Research Company that provides blood platelets market statistics, including blood platelets industry global market size, regional shares, competitors with a blood platelets market share, detailed blood platelets market segments, market trends and opportunities, and any further data you may need to thrive in the blood platelets industry. This blood platelets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood platelets market size has grown strongly in recent years. It will grow from$6.27 billion in 2024 to $6.72 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increasing number of surgeries, the rising incidence of traumatic injuries, the 6.27% prevalence of autoimmune diseases, the growing incidence of chronic diseases, and the increasing prevalence of thrombocytopenia.

The blood platelets market size is expected to see strong growth in the next few years. It will grow to$8.79 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to the increasing number of trauma cases, the rise in the number of blood banks, a growing preference for allogeneic blood transfusion therapies, the aging population, and the increasing need for platelets in wound healing. Key trends expected during this period include the development of automated platelet apheresis systems, advancements in platelet storage technologies, platelet-rich plasma (PRP) therapies, a shift toward leukoreduced platelets, the emergence of artificial platelet substitutes, gene editing for platelet disorders, and automated donor screening.

The growing prevalence of blood disorders is expected to propel the expansion of the blood platelets market. Blood disorders refer to conditions that impact the function, production, or components of blood, including red blood cells, white blood cells, platelets, or plasma, leading to issues such as anemia, clotting disorders, or immune system deficiencies. The increasing prevalence of these disorders is largely due to the aging population, as the natural decline in bone marrow function with age makes older adults more vulnerable to conditions such as anemia, thrombocytopenia, and clotting disorders. Blood platelets are crucial in the treatment of blood disorders, as they regulate blood clotting, preventing excessive bleeding and supporting wound healing. For example, in April 2024, the Perth Blood Institute, a non-profit organization based in Australia, reported that the number of people diagnosed with hemophilia, a rare genetic disorder where blood doesn't clot properly due to a lack of clotting factors, reached 257,146 in 2022, up from 233,577 in 2021. Therefore, the rising prevalence of blood disorders is significantly contributing to the growth of the blood platelets market.

Major players in the blood platelet market are focusing on developing innovative solutions such as platelet pooling to extend shelf life, improve availability, and assist blood centers in meeting the increasing demand for transfusions. Platelet pooling involves combining platelets from multiple whole blood donations to create a single platelet unit for transfusion, thereby improving availability, efficiency, and resource utilization in blood supply management. For instance, in February 2023, Terumo Blood and Cell Technologies, a US-based medical technology company, launched the IMUGARD WB platelet pooling set after receiving U.S. Food and Drug Administration (FDA) clearance. This innovation extends the shelf life of whole blood-derived platelets from five to seven days, improving platelet availability for transfusion. It also offers an alternative platelet supply to address rising demand and donor shortages, helping blood centers enhance inventory management and reduce waste.

In December 2023, Sysmex Corporation, a Japan-based healthcare and diagnostics company, increased its stake in Megakaryon Corporation for an undisclosed amount. With this acquisition, Sysmex aims to accelerate the commercialization of high-quality, induced pluripotent stem (iPS) cell-derived platelets by utilizing Megakaryon's technology, strengthening synergies within the group, and advancing regenerative medicine through automation and quality control innovations. Megakaryon Corporation, a Japan-based biotechnology company, specializes in the production of iPS cell-derived platelets for safer and more sustainable blood transfusions.

Major players in the blood platelets market are Pfizer Inc., Johnson & Johnson, Bayer AG, Fresenius Kabi, Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Grifols S.A., Terumo Corporation, American Red Cross, BioMarin Pharmaceutical Inc., Miltenyi Biotec, Kedrion Biopharma Inc., LFB Group, Bio Products Laboratory Limited, Sanquin, Macopharma, Biotest AG, Cerus Corporation, ADMA Biologics Inc., Octapharma AG, Kamada Ltd., and HemaCare.

North America was the largest region in the blood platelets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in blood platelets report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the blood platelets market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The blood platelets market consists of sales of platelet apheresis kits, platelet storage systems, platelet-derived growth factors (PDGFs), platelet function analyzers and platelet transfusion services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Platelets Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood platelets market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for blood platelets ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood platelets market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Blood Platelets Market Characteristics

3. Blood Platelets Market Trends And Strategies

4. Blood Platelets Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blood Platelets Growth Analysis And Strategic Analysis Framework

6. Blood Platelets Market Segmentation

7. Blood Platelets Market Regional And Country Analysis

8. Asia-Pacific Blood Platelets Market

9. China Blood Platelets Market

10. India Blood Platelets Market

11. Japan Blood Platelets Market

12. Australia Blood Platelets Market

13. Indonesia Blood Platelets Market

14. South Korea Blood Platelets Market

15. Western Europe Blood Platelets Market

16. UK Blood Platelets Market

17. Germany Blood Platelets Market

18. France Blood Platelets Market

19. Italy Blood Platelets Market

20. Spain Blood Platelets Market

21. Eastern Europe Blood Platelets Market

22. Russia Blood Platelets Market

23. North America Blood Platelets Market

24. USA Blood Platelets Market

25. Canada Blood Platelets Market

26. South America Blood Platelets Market

27. Brazil Blood Platelets Market

28. Middle East Blood Platelets Market

29. Africa Blood Platelets Market

30. Blood Platelets Market Competitive Landscape And Company Profiles

31. Blood Platelets Market Other Major And Innovative Companies

32. Global Blood Platelets Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Platelets Market

34. Recent Developments In The Blood Platelets Market

35. Blood Platelets Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â